HRT: Summary for ARRHYTHMIA RES TECH - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 8:48am EST - Canadian Markets open in 42 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Arrhythmia Research Technology Inc. (HRT)

On Feb 9: 5.15 USD 0.00 (0.00%)

MORE ON HRT

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

ARRHYTHMIA RES TECH (AMEX:HRT) Delayed quote data

Last Trade:	5.15 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	5.09
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	1.38 - 6.49
Volume:	0
Avg Vol (3m):	8,873.02
Market Cap:	13.78M
P/E (ttm):	50.00
EPS (ttm):	0.10
Div & Yield:	N/A (N/A%)

Arrhythmia Research Technology Inc. (HRT)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add HRT to Portfolio

Download Data

HEADLINES

•	Arrhythmia Research Technology, Inc. Announces OEM Version of PREDICTOR(TM) SAECG Software
	Marketwire (Mon, Feb 8)

•	Micron Products Announces ISO 13485:2003 Certification
	Marketwire (Wed, Jan 20)

•	Arrhythmia Research Technology, Inc. Declares Cash Dividend
	Marketwire (Tue, Jan 19)

•	ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Financials
	EDGAR Online Financials (Fri, Nov 6)

•	ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition
	EDGAR Online (Fri, Oct 30)

•	Arrhythmia Research Technology, Inc. Announces Results for Third Quarter 2009
	Marketwire (Wed, Oct 28)

•	ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Tue, Aug 4)

•	ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition
	EDGAR Online (Fri, Jul 31)

•	Arrhythmia Research Technology, Inc. Announces Results for Second Quarter 2009
	Marketwire (Thu, Jul 30)

•	ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Mon, May 11)

More Headlines for HRT...

ANALYST

EPS Est (next year) (Dec-69) :	N/A
EPS Est (in 2 years) (Dec-69) :	N/A
Avg Rec (current)*:	N/A
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Arrhythmia Research Technology, Inc. engages in the development and licensing of medical software, which acquires data and analyzes electrical impulses of the heart to detect and aid in the treatment of potentially lethal arrhythmias.

Full Company Profile

Add to Portfolio

Email to a Friend

•